.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Teva
Deloitte
Healthtrust
Baxter
Julphar
Johnson and Johnson
Citi
Fuji
QuintilesIMS

Generated: July 20, 2017

DrugPatentWatch Database Preview

ACCUPRIL Drug Profile

« Back to Dashboard

Which patents cover Accupril, and what generic Accupril alternatives are available?

Accupril is a drug marketed by Pfizer Pharms and is included in one NDA.

The generic ingredient in ACCUPRIL is quinapril hydrochloride. There are eleven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the quinapril hydrochloride profile page.

Summary for Tradename: ACCUPRIL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list35
Clinical Trials: see list6
Patent Applications: see list1,355
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACCUPRIL at DailyMed

Pharmacology for Tradename: ACCUPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-001Nov 19, 1991ABRXYesNo► Subscribe► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-004Nov 19, 1991ABRXYesYes► Subscribe► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-002Nov 19, 1991ABRXYesNo► Subscribe► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-003Nov 19, 1991ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ACCUPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-003Nov 19, 19915,747,504*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-002Nov 19, 19914,344,949*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-002Nov 19, 19914,743,450*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-001Nov 19, 19914,344,949*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-002Nov 19, 19915,684,016*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Army
AstraZeneca
Fish and Richardson
Chinese Patent Office
Daiichi Sankyo
Colorcon
Medtronic
Cantor Fitzgerald
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot